Literature DB >> 21258056

Rituximab in anti-glomerular basement membrane disease.

Y Shah1, A Mohiuddin, C Sluman, I Daryanani, T Ledson, A Banerjee, A Crowe, P McClelland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21258056     DOI： 10.1093/qjmed/hcr001

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


× No keyword cloud information.
  10 in total

1.  A unique way to treat Goodpasture's disease.

Authors:  Maya Narayanan; Isabel Casimiro; Raimund Pichler
Journal:  BMJ Case Rep       Date:  2014-11-24

2.  Rituximab for the treatment of refractory anti-glomerular basement membrane disease.

Authors:  Xue-Fen Yang; Xiao-Yu Jia; Xiao-Juan Yu; Zhao Cui; Ming-Hui Zhao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 3.  Goodpasture's autoimmune disease - A collagen IV disorder.

Authors:  Vadim Pedchenko; A Richard Kitching; Billy G Hudson
Journal:  Matrix Biol       Date:  2018-05-12       Impact factor: 11.583

4.  Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy.

Authors:  Ghassan Bandak; Bruce A Jones; Jian Li; Jerry Yee; Kausik Umanath
Journal:  Clin Kidney J       Date:  2014-01-12

5.  What is new in the management of rapidly progressive glomerulonephritis?

Authors:  George H B Greenhall; Alan D Salama
Journal:  Clin Kidney J       Date:  2015-02-19

6.  Crescentic glomerulonephritis with dual positive anti-GBM and C-ANCA/PR3 antibodies.

Authors:  Bolanle A Omotoso; Helen P Cathro; Rasheed A Balogun
Journal:  Clin Nephrol Case Stud       Date:  2016-04-29

7.  Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease.

Authors:  M Heitz; P L Carron; G Clavarino; T Jouve; N Pinel; F Guebre-Egziabher; L Rostaing
Journal:  BMC Nephrol       Date:  2018-09-20       Impact factor: 2.388

8.  Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders.

Authors:  Celine Kaegi; Benjamin Wuest; Jens Schreiner; Urs C Steiner; Alessandra Vultaggio; Andrea Matucci; Catherine Crowley; Onur Boyman
Journal:  Front Immunol       Date:  2019-09-06       Impact factor: 7.561

Review 9.  Rituximab in treatment of anti-GBM antibody glomerulonephritis: A case report and literature review.

Authors:  Mayu Uematsu-Uchida; Takehiro Ohira; Shigeki Tomita; Hiroshi Satonaka; Akihiro Tojo; Toshihiko Ishimitsu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

10.  Rituximab use in adult glomerulopathies and its rationale.

Authors:  Joana Eugénio Santos; David Fiel; Ricardo Santos; Rita Vicente; Rute Aguiar; Iolanda Santos; Manuel Amoedo; Carlos Pires
Journal:  J Bras Nefrol       Date:  2019-12-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.